Search Results

1 - 10 of 1,108 items :

  • lung cancer x
Clear All
Molecular Diagnosis of Lung Cancer

References 1. Centers for Disease Control and Prevention. Compressed mortality file 1999-2011 [CD- ROM]. Atlanta: National Center for Health Statistics; 2014. 2. National Oncological Hospital, Bulgarian National Cancer Resistry. Cancer Incidence in Bulgaria. Sofia: Paradigma; 2014, 170 p. 3. Chilingirova N, Balabanski L, Toncheva D, Kurteva G, Damyanov D, Chilingirov P. Identifying the genetic landscape of squamous cell carcinoma (SCC) and adenosquamous carcinoma (ASC) of the lung using next- generation sequencing (NGS). Ann Oncol. 2015;26 Suppl

Open access
Occupational exposure and lung cancer risk - Study in two different Romanian areas

:// 10. Simonato, L. & Saracci, R. (1983). Cancer, occupational. In International Labor Organization (ILO), Encyclopedia of Occupational Safety and Health . pp. 369-375. Geneva, Switzerland: ILO. 11. De Matteis, S., Consonni, D. & Bertazzi, P.A. (2008). Exposure to occupational carcinogens and lung cancer risk. Evolution of epidemiological estimates of attributable fraction. Acta Biomed, 79, 34-42. 12. Siemiatycki, J., Richardson, L. & Straif, K. et al. (2004). Listing occupational carcinogens. Environ Health Perspect, 112(15), 1447

Open access
Lung Cancer - Clinical Implications

References Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50 : 7-33. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350 : 379-92. Stupp R, Monnerat C, Turrisi AT 3rd, Perry MC, Leyvraz S. Small cell lung cancer: state of the art and future perspectives. Lung Cancer 2004; 45 : 105-7. Booth CM, Shepherd F. Adjuvant chemotherapy for resected non-small cell lung cancer

Open access
Prognostic Intake of Molecular Markers in Lung Cancer The Pulmonologist Point Of View

(6), 1776-1786. doi: 10.1183/09031936.00150813 4. Detterbeck, F. C., Boffa, D. J., Kim, A. W., & Tanoue, L. T. (2017). The Eighth Edition Lung Cancer Stage Classification. CHEST Journal, 151(1), 193-203.. 5. Goldstraw, P., Chansky, K., Crowley, J., Rami- Porta, R., Asamura, H., Eberhardt, W. E., ... & Rami-Porta, R. (2016). The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Journal of Thoracic Oncology, 11(1), 39

Open access
The Importance of Bronchoscopy in Early Lung Cancer (LC) Diagnosis

References 1. Harikrishna, J., Sukaveni, V., Kumar, D.P. & Mohan, A. (2012). Cancer and tuberculosis. J Indian Acad Clin Med, 13 (2), 142-144. 2. Mascaux, C., Peled, N., Garg, K., Kato, Y., Wynes, M.W. & Hirsch, F.R. (2010). Early detection and screening of lung cancer. Expert review of molecular diagnostics, 10 (6), 799-815.. 3. Robin, L. & Wittekind, C. (2002). TNM, clasificarea tumorilor maligne . (Ed. 6). Uniunea Internaţională de Luptă împotriva Cancerului. . 4. Ulmeanu R. et al, (2009). Cancerul bronhopulmonar, Actualitati in

Open access
Lung cancer mortality and radon exposure in Russia

References 1. ICRP. (2010). Lung cancer risk from radon and progeny and statement on radon. (ICRP Publication 115). Ann. ICRP , 40 (1). ICRP 2010 Lung cancer risk from radon and progeny and statement on radon. (ICRP Publication 115) Ann. ICRP 40 1 2. Lubin, J. H., Boice, J. D., Edling, C., Hornung, R. W., Howe, G., Kunz, E., Kusiak, R. A., Morrison, H. I., Radford, E. P., Samet, J. M., Tirmarche, M., Woodward, A., Xiang, Y. S., & Pierce, D. A. (1994). Radon and lung cancer risk: A joint analysis of 11 underground miner

Open access
Recommendations For Clinical Use Of Tumor Markers In Lung Cancer

References Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50 : 7-33. Stieber P, Dienemann H, Hasholzner U, Fabricius PG, Schambeck C, Weinzierl M, et al. Comparison of CYFRA 21-1, TPA, and TPS in lung cancer, urinary bladder cancer, and benign diseases. Int J Biol Markers 1994; 9 : 82-8. Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, et al. Cytokeratin 19 fragment CYFRA 21-1 compared with

Open access
Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients

References 1. Cancer in Slovenia 2007 . Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2010. 2. Debevec L, Debeljak A, Eržen J, Kovač V, Kern I. Characterisation of lung cancer patients, their actual treatment and survival: experience in Slovenia. Radiol Oncol 2005; 39: 115-21. 3. Lekic M, Kovac V, Triller N, Knez L, Sadikov A, Cufer T. Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical

Open access
Angiogenesis and Non Small Cell Lung Cancer

References Gridelli C, Maione P, Rossi A, De Marinis F. The role of bevacizumab in the treatment of nonsmall cell lung cancer: current indications and future developments. Oncologist 2007; 12(10): 1183-1193. Dundar E, Oner U, Peker BC, Metintas M, Isiksoy S, Ak G. The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma. J Int Med Res 2008; 36(1): 88-95. Giaccone G. The potential of antiangiogenic therapy in non-small cell

Open access
High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer

Introduction Lung cancer accounted for approximately 13% of total cancer diagnoses and was the most frequently diagnosed cancer worldwide in 2012. 1 In 2013, the number of lung cancer deaths was estimated to be 1.6 million, while 34.7 million disability-adjusted life-years were also caused. Specifically, it was the most common cause of cancer death globally, including both developing and developed countries. 2 Early-stage lung cancer is treated via lung resection. However, an increasing number of people are now receiving radiotherapy, including

Open access